Corporate Finance

New research reveals AI is not just hype for manufacturers. Early adopters see real value in months, leaving hesitant competitors far behind.

Cambridge Savings is acquiring NH's First Seacoast Bancorp in a deal that expands its footprint and signals major consolidation in regional community banking.

As federal funding for psychedelic therapy surges, practitioners warn that a critical lack of patient preparation and integration support could undermine healing.

As SandRidge Energy reports Q1 results, investors watch to see if it capitalized on high oil prices while navigating a chaotic natural gas market.

A new platform feature gates content behind social actions like follows, promising creators both audience growth and revenue. But what is the cost to users?

A new alliance of 21 biotech firms aims to forge a national strategy, warning that America's long-held lead in medical innovation is under pressure.

With its 100th study launch and a perfect client retention rate, Atreo's agile RTSM platform is challenging the rigid, slow pace of traditional trial tech.

Germany's startups attracted €1.7B in Q1 2026, fueled by US investors and a massive bet on artificial intelligence, signaling a new era for its ecosystem.

Backed by Mastercard, Visa, and top VCs, Astrada is building the real-time data infrastructure for the coming age of AI-managed enterprise finance.

On World Hand Hygiene Day, experts warn of waning habits post-pandemic. Discover the simple, life-saving power of a 20-second scrub and its huge impact.

Xali Gold is advancing its Pico Machay project in Peru, where vast gold potential at historically low prices meets a notoriously tough regulatory landscape.

NiSource secures top sustainability honors for over a decade. Explore how its deep ESG strategy is setting an industry benchmark and attracting investors.

With profits up and a new CEO, TVA is pouring billions into new generation, betting on advanced nuclear power to meet soaring demand from data centers.

A second major roof donation from Monarch Roofing provides a lifeline to All 4 Paws, highlighting a growing animal welfare crisis and a model for community support.

Jeito Capital appoints top talent and BD partners, signaling a strategic shift in biopharma investing where deep operational expertise is now king.

New research reveals CFO salaries are surging toward $4M, yet tenures are plummeting. A look at the high-risk, high-reward world of modern finance chiefs.

A new 'dream team' of experts will guide AI development to create non-invasive tools for a deadly lung disease, aiming to replace painful procedures.

California's LBC Capital expands its $1B bridge lending platform nationwide, betting its conservative underwriting can capture a growing private credit market.

UK biotech Cytospire Therapeutics secures major funding to push its safer, more selective gamma delta T-cell engager into clinical trials for solid tumors.

UK biotech Cytospire secures a major Series A to bring its novel pan-gamma delta T cell engagers, targeting tough solid tumors, into clinical trials.